TL;DR: Correlia Biosystems is a Y Combinator Winter 2018 startup Next-gen blood testing to provide 1000x more data to pharma companies, currently inactive with a team of 16.
Next-gen blood testing to provide 1000x more data to pharma companies
Last verified:
Correlia Biosystems is a UC Berkeley spinoff company based in Berkeley, CA. Correlia develops innovative microscale tools that accelerate rapid quantification of biomolecules. Our versatile "SimpleScan" technology opens up new biological questions from one microliter of sample, with rapid results that allow for dynamic monitoring of protein expression profiles (rather than simple end-point measurement). Applications range from enabling next-gen proteomic data sets to point-of-care diagnostics.
Built by LemStudio
Yes. Correlia Biosystems was funded by Y Combinator in the Winter 2018 batch. Next-gen blood testing to provide 1000x more data to pharma companies
Correlia Biosystems is a UC Berkeley spinoff company based in Berkeley, CA. Correlia develops innovative microscale tools that accelerate rapid quantification of biomolecules. Our versatile "SimpleScan" technology opens up new biological questions from one microliter of sample, with rapid results that allow for dynami…
Correlia Biosystems was part of Y Combinator's Winter 2018 batch.
Correlia Biosystems has a team of 16 people according to Y Combinator's directory.
Correlia Biosystems is currently listed as Inactive with a team of 16 in Y Combinator's directory.
Loading interactive view…